Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs Lidocaine for Propofol Injection Pain
NCT07422558Not yet recruiting
- Sponsor
- Hayatabad Medical Complex
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
01
Overview
Randomised trial of nalbuphine in procedural pain (2 arms), sponsored by Hayatabad Medical Complex. Primary endpoint: Frequency of propofol-induced injection pain. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT07422558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07422558.